GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NexgenRx Inc (TSXV:NXG) » Definitions » Ending Cash Position

NexgenRx (TSXV:NXG) Ending Cash Position : C$1.88 Mil (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is NexgenRx Ending Cash Position?

NexgenRx's Ending Cash Position for the quarter that ended in Dec. 2023 was C$1.88 Mil.

NexgenRx's quarterly Ending Cash Position increased from Jun. 2023 (C$1.27 Mil) to Sep. 2023 (C$1.94 Mil) but then declined from Sep. 2023 (C$1.94 Mil) to Dec. 2023 (C$1.88 Mil).

NexgenRx's annual Ending Cash Position declined from Dec. 2021 (C$2.32 Mil) to Dec. 2022 (C$1.77 Mil) but then increased from Dec. 2022 (C$1.77 Mil) to Dec. 2023 (C$1.88 Mil).


NexgenRx Ending Cash Position Historical Data

The historical data trend for NexgenRx's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NexgenRx Ending Cash Position Chart

NexgenRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.80 2.32 1.77 1.88

NexgenRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.77 1.26 1.27 1.94 1.88

NexgenRx Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

NexgenRx's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.767+0.11
=1.88

NexgenRx's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.938+-0.061
=1.88


NexgenRx Ending Cash Position Related Terms

Thank you for viewing the detailed overview of NexgenRx's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


NexgenRx (TSXV:NXG) Business Description

Traded in Other Exchanges
Address
191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6
NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.
Executives
Paul Crossett 10% Security Holder